retatrutide triple agonist glp1 gip glucagon vs Tirzepatide Compared Retatrutide is considered the newest

Quick Answer: Yes, GLP-1 receptor agonists effectively reduce visceral fat, as demonstrated by clinical trials using CT and MRI imaging showing significant decreases in visceral adipose tissue volume alongside improvements in waist circumference and cardiometabolic markers

Retatrutides once-weekly dosing regimen is another advantage, providing convenience and ease of use for patients

in Textbook of Diabetes 4th edn (eds Holt, R

Mushrooms as potential therapeutic agents in the treatment of cancer: Evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts